## Abstract ## BACKGROUND Clinical trials may offer patients innovative therapeutic options with potentially better outcomes, which are particularly relevant for patients afflicted with lung carcinoma, because current therapies provide only modest survival benefits. Only approximately 5% of patien
Predictors of anticoagulation in hospice patients with lung cancer
โ Scribed by Holly M. Holmes; Kevin T. Bain; Ali Zalpour; Ruili Luo; Eduardo Bruera; James S. Goodwin
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 187 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND. Providing appropriate surgical treatment for women with ovarian cancer is one of the most effective ways to improve ovarian cancer outcomes. In this study, the authors identified factors that were associated with a measure of comprehensive surgery, so that interventions
## Abstract ## BACKGROUND. The authors assessed patterns of perioperative chemotherapy use in elderly patients with resected stage I, II, or IIIA nonsmall cell lung cancer (NSCLC) from 1992 to 2002. ## METHODS. By using data from the Surveillance, Epidemiology, and End Results Program, 11,807 pa
There are only limited population-based data available regarding the risk of developing a second cancer after a diagnosis of lung carcinoma. ## METHODS. Data collected from the Cancer Registry of the Swiss Canton of Vaud (comprised of approximately 600,000 inhabitants) were used to estimate the i